These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24617415)

  • 1. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
    Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
    Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.
    Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G
    Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
    Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
    Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective proliferative potential of MSCs from pediatric myelodysplastic syndrome patients is associated with cell senescence.
    Liu Q; Zhu H; Dong J; Li H; Zhang H
    Int J Clin Exp Pathol; 2015; 8(10):13059-66. PubMed ID: 26722501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.
    Geyh S; Oz S; Cadeddu RP; Fröbel J; Brückner B; Kündgen A; Fenk R; Bruns I; Zilkens C; Hermsen D; Gattermann N; Kobbe G; Germing U; Lyko F; Haas R; Schroeder T
    Leukemia; 2013 Sep; 27(9):1841-51. PubMed ID: 23797473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome.
    Zhang YZ; Zhao DD; Han XP; Jin HJ; Da WM; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):813-8. PubMed ID: 18718067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
    Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
    Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells.
    Boland GM; Perkins G; Hall DJ; Tuan RS
    J Cell Biochem; 2004 Dec; 93(6):1210-30. PubMed ID: 15486964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Despite differential gene expression profiles pediatric MDS derived mesenchymal stromal cells display functionality in vitro.
    Calkoen FG; Vervat C; van Pel M; de Haas V; Vijfhuizen LS; Eising E; Kroes WG; 't Hoen PA; van den Heuvel-Eibrink MM; Egeler RM; van Tol MJ; Ball LM
    Stem Cell Res; 2015 Mar; 14(2):198-210. PubMed ID: 25679997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine-Like Receptor 1 Is a Novel Wnt Target Gene that Regulates Mesenchymal Stem Cell Differentiation.
    Muruganandan S; Govindarajan R; McMullen NM; Sinal CJ
    Stem Cells; 2017 Mar; 35(3):711-724. PubMed ID: 27733019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes.
    Klaus M; Stavroulaki E; Kastrinaki MC; Fragioudaki P; Giannikou K; Psyllaki M; Pontikoglou C; Tsoukatou D; Mamalaki C; Papadaki HA
    Stem Cells Dev; 2010 Jul; 19(7):1043-54. PubMed ID: 19788374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
    Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
    Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgo biloba extract promotes osteogenic differentiation of human bone marrow mesenchymal stem cells in a pathway involving Wnt/β-catenin signaling.
    Gu Q; Chen C; Zhang Z; Wu Z; Fan X; Zhang Z; Di W; Shi L
    Pharmacol Res; 2015 Jul; 97():70-8. PubMed ID: 25917209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteogenic lineage commitment of mesenchymal stem cells from patients with ossification of the posterior longitudinal ligament.
    Harada Y; Furukawa K; Asari T; Chin S; Ono A; Tanaka T; Mizukami H; Murakami M; Yagihashi S; Motomura S; Ishibashi Y
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1014-20. PubMed ID: 24361881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of WNT/β-catenin signaling in rejuvenating myogenic differentiation of aged mesenchymal stem cells from cardiac patients.
    Brunt KR; Zhang Y; Mihic A; Li M; Li SH; Xue P; Zhang W; Basmaji S; Tsang K; Weisel RD; Yau TM; Li RK
    Am J Pathol; 2012 Dec; 181(6):2067-78. PubMed ID: 23026201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
    Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
    Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.
    Medyouf H; Mossner M; Jann JC; Nolte F; Raffel S; Herrmann C; Lier A; Eisen C; Nowak V; Zens B; Müdder K; Klein C; Obländer J; Fey S; Vogler J; Fabarius A; Riedl E; Roehl H; Kohlmann A; Staller M; Haferlach C; Müller N; John T; Platzbecker U; Metzgeroth G; Hofmann WK; Trumpp A; Nowak D
    Cell Stem Cell; 2014 Jun; 14(6):824-37. PubMed ID: 24704494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of SDF-1 gene in bone marrow mesenchymal stem cells of patients with myelodysplastic syndrome].
    Zhang YZ; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):281-4. PubMed ID: 16638197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.